Charles Schwab’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Charles Schwab’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-111,778	Closed	-$19.3M	–	3217
2015 Q1	$19.3M	Buy	111,778 +10,123	+10%	+$1.49M	0.03%	581
2014 Q4	$11.7M	Buy	101,655 +7,335	+8%	+$889K	0.02%	785
2014 Q3	$14.7M	Sell	94,320 -359,306	-79%	-$52.1M	0.02%	593
2014 Q2	$56M	Buy	453,626 +267,841	+144%	+$29.6M	0.09%	211
2014 Q1	$19.3M	Buy	185,785 +7,499	+4%	+$768K	0.03%	479
2013 Q4	$16M	Sell	178,286 -38,657	-18%	-$3.08M	0.03%	502
2013 Q3	$15.4M	Buy	216,943 +118,626	+121%	+$8.17M	0.03%	477
2013 Q2	$6.6M	Buy	+98,317	New	+$5.62M	0.01%	817

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Charles Schwab's SLXP Position: Q2 2015 in Review

Charles Schwab sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 111,778 shares — an estimated $19.3M sold.

Charles Schwab first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $56M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Charles Schwab reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Charles Schwab sold 111,778 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $19.3M.
Charles Schwab first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Charles Schwab's SALIX PHARMACEUTICALS LTD DEL position peaked at $56M in Q2 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.